Zanamivir clinical trials
Also written Relenza.
How each study uses Zanamivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Zanamivir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 Jul 1999 · RELENZA · NDA 021036 (FDA, Drugs@FDA)
- European Union
- 26 Apr 2019 · Dectova · EMEA/H/C/004102 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 8
GlaxoSmithKline (7) · University of Missouri-Columbia (1) · Mount Sinai Hospital, Canada (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · George Washington University (1) · University of Oxford (1) · Assistance Publique - Hôpitaux de Paris (1)
Often tested with
Tested in the same studies.
Oseltamivir (6) · Influenza Vaccines (1) · Favipiravir (1) · Baloxavir (1) · Molnupiravir (1) · Peramivir (1) · Laninamivir (1) · Amantadine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Zanamivir.
- Jan 2027A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaPhase 2 · University of Oxford
- Aug 2027Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)Phase 2 · George Washington University
Studies
Open first, then newest update. How each study uses Zanamivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)RecruitingPhase 2George Washington UniversityNCT04597437Written as ZanamivirHow we know
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as ZanamivirHow we know
- An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza InfectionCompletedPhase 2GlaxoSmithKlineNCT04494412Written as ZanamivirHow we know
- Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 DiabetesCompletedPhase 2University of Missouri-ColumbiaNCT04867707Written as ZanamivirHow we know
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With InfluenzaCompletedPhase 3GlaxoSmithKlineNCT01231620Written as ZanamivirHow we know
- A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza InfectionCompletedPhase 3GlaxoSmithKlineNCT01527110Written as Intravenous (IV) zanamivirHow we know
- Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese MalesCompletedPhase 1GlaxoSmithKlineNCT01428479Written as GR121167 SolutionHow we know
- Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 DaysCompletedPhase 1GlaxoSmithKlineNCT00989404Written as ZanamivirHow we know
- Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese AdultsCompletedPhase 1GlaxoSmithKlineNCT02377401Written as ZanamivirHow we know
- Zanamivir Versus Trivalent Split Virus Influenza VaccineCompletedPhase 3Mount Sinai Hospital, CanadaNCT00784784Written as ZanamivirHow we know
- Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaCompletedPhase 3Jiangsu Simcere Pharmaceutical Co., Ltd.NCT01459081Written as ZanamivirHow we know
- Evaluation of Efficacity and Safety of Oseltamivir and ZanamivirTerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT00799760Written as oseltamivir + zanamivirHow we know
- A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza InfectionTerminatedPhase 3Chinese University of Hong KongNCT00979667Written as ZanamivirHow we know
- Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A InfectionTerminatedPhase 2Hospices Civils de LyonNCT00830323Written as oseltamivir + zanamivirHow we know
- A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy SubjectsWithdrawnPhase 1GlaxoSmithKlineNCT00540501Written as Oseltamivir and Intravenous ZanamivirHow we know
- Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00921726Written as ZanamivirHow we know
As the comparator · 1 — what is tested is compared with Zanamivir
Codes
What other systems call Zanamivir · ClinicalTrials.gg INT008881
- MeSH (NLM) D053243ZanamivirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) L6O3XI777IZANAMIVIRConfirmed FDA, NLM, Wikidata
- RxNorm 69722Confirmed FDA, Wikidata
- Wikidata Q146075zanamivirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47786ZanamivirOne source FDA
- DrugBank DB00558One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D053243 | Zanamivir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | L6O3XI777I | ZANAMIVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69722 | — | Confirmed FDA, Wikidata |
| Wikidata | Q146075 | zanamivir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47786 | Zanamivir | One source FDA |
| DrugBank | DB00558 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.